Type 1 diabetes is an autoimmune condition that requires lifelong insulin therapy. Its global impact continues to rise, with more than 9 million people living with the condition. Delayed diagnosis postpones essential treatment and poses serious health risks.
A new policy brief by the International Diabetes Federation (IDF) and the International Society for Pediatric and Adolescent Diabetes (ISPAD) provides advocates, healthcare professionals and policymakers with recommendations to advance type 1 diabetes screening and early diagnosis.
The IDF-ISPAD policy brief:
- Highlights the impact of type 1 diabetes worldwide.
- Underscores the severity and potentially life-threatening consequences of a late type 1 diabetes diagnosis.
- Showcases the latest techniques to screen and potentially delay the progression of type 1 diabetes.
- Provides policy recommendations to improve screening and early diagnosis of type 1 diabetes.
- Shares lived experiences of living with type 1 diabetes from different regions.
Download the policy brief
Policy brief
Detect early, act early: Improving diagnosis of type 1 diabetes
A joint policy brief with the International Society for Pediatric and Adolescent Diabetes (ISPAD) that provides advocates, healthcare professionals and policymakers with recommendations to advance type 1 diabetes screening and early diagnosis.
IDF-ISPAD-Policy Brief-T1D-screening-early-diagnosis-
pdf
2MB
